Purchase Order HT001422P0201

Award Date 8/26/22
Potential Completion Date 9/30/22
Potential Value $243K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, to provide COVID-19 testing kits. The $230,850 contract has a period of performance from July 2020 to July 2021 and is not associated with a set-aside program. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts to provide diagnostic testing services,...
This is a $2,474,747.75 fixed-price purchase order awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the provision of testing kits and panels for Bloodstream Infections, COVID-19, Meningitis/Encephalitis, and other infectious diseases. The contract has an ultimate completion date of April 29, 2026 and does not utilize a set-aside designation. Biofire Diagnostics LLC is an experienced federal contractor, holding several indefinite...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The one-year, $808,537.12 delivery order contract is for Firm Fixed Price infectious disease testing products and services, including molecular diagnostic testing, COVID-19 testing reagents and equipment, maintenance services, and supply of reagents and test...
This federal contract award, with an ID of HT001414A0010|0003, was issued by the Defense Health Agency (DHA) to Biofire Diagnostics LLC, a foreign-owned, for-profit biotechnology company. The $290,000.00 contract is a BPA Call under a larger BPA, providing firm fixed-price diagnostic testing products and services, including FilmArray diagnostic systems, COVID-19 testing reagents, infectious disease testing panels, equipment maintenance, and cost-per-test solutions. The contract supports critical...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease...
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $121,440.00 firm fixed-price contract is for the provision of BIOFIRE diagnostic products and services, issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a firm fixed price blanket purchase agreement to Biofire Diagnostics LLC for $156,363.20 to provide wide film array testing services inclusive of equipment, service, training, reagents, and other items needed to perform tests through September 30, 2023. Biofire Diagnostics LLC is a foreign owned, for-profit biotech company that specializes in syndromic infectious disease testing. This...
This federal contract award was made by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $225,000 firm fixed-price purchase order is for a Film Array Torch Module Advance Testing Solution System. No set-aside was used. Biofire Diagnostics has received numerous federal contracts and task orders, including with the Department of Veterans Affairs, Indian Health Services, and Department of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a firm fixed price blanket purchase agreement to Biofire Diagnostics LLC for $254,628.10 to provide wide film array testing services inclusive of equipment, service, training, reagents, and other items needed to perform tests through September 30, 2023. Biofire Diagnostics LLC is a foreign owned, for-profit biotech company that specializes in syndromic infectious disease testing. This...
This federal contract award to Biofire Diagnostics LLC, a foreign-owned for-profit organization, is for the provision of COVID-19 tests. The $112,000.00 firm-fixed-price purchase order was issued by the Department of the Air Force Air Combat Command, with a period of performance through April 17, 2020. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards as a prime contractor to provide a variety of goods and services...

The Defense Health Agency awarded a firm-fixed-price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide molecular diagnostic testing kits. The $242,760 contract has a completion date of September 30, 2022 and was not set aside for any particular business type. Biofire Diagnostics is a leader in syndromic infectious disease testing and has held numerous federal contracts to supply a range of testing products and services, including to the Department of Veterans Affairs, Indian Health Service, and Department of State. This award appears to be part of Biofire's existing General Services Administration Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests.

Generated 4/24/24, 9:09 AM